News, updates, and stories.

Novellia Data Shown to Optimize Risk Profiling to Inform HER2+ Breast Cancer Care

-New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of serious adverse events, such as interstitial lung disease (ILD), in real-world settings -Project EVOLVE, funded by Daiichi Sankyo and AstraZeneca, to be presented at the 2024 San Antonio Breast Cancer Symposium

Novellia and University of Alabama at Birmingham Study Examines Biomarker Testing Practices for Non-Small Cell Lung Cancer

-Research study presented at the 2024 ASCO Quality Care Symposium uses Novellia's AI-enabled technology and personal health record platform to unlock insights that can inform patient care NEW YORK, September 30, 2024 -- Novellia, Inc., an AI-enabled personal health data company dedicated to bridging the gap between real-world